The activities of the Let’s Talk Prostate Cancer (LTPC) Expert Group are funded by Astellas Pharma Inc., Amgen Inc and Pfizer Inc, which collectively contribute to and support the objectives of the Expert group.
Astellas Pharma Inc. have full and exclusive editorial control over the LTPC Website

Shining Light on Global Practices in Prostate Cancer Policy and Care

By admin

On 20 May, Let’s Talk Prostate Cancer (LTPC) hosted the international event “Shining Light on Global Practices in Prostate Cancer Policy and Care”, gathering experts, clinicians, and patient advocates from the EU and Latin America. Held virtually, the roundtable created space for a cross-regional exchange on early detection strategies, systemic challenges, and policy solutions in […]

LTPC EVENT REPORT: Uniting for Prostate Cancer: Advancing Screening and Care in the EU

By admin

On 5 December, Let’s Talk Prostate Cancer organised the event “Uniting for Prostate Cancer: Advancing Screening and Care in the EU,” at the European Parliament, hosted by MEP Romana Jerkovic. The event brought together European Union (EU) policymakers, patient advocates, healthcare authorities, and key stakeholders to discuss the importance of early screening and detection of […]